Search
for
Sort by
Research 811–840 of 1000+
- Androgen Action in the Ovary
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Prolactin: an emerging force along the cutaneous–endocrine axis
- Anti-androgenic and Hair Growth Promoting Activities of Lygodii Spora (Spore of Lygodium japonicum) I. Active Constituents Inhibiting Testosterone 5.ALPHA.-Reductase.
- Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia
- Shedding: How to manage a common cause of hair loss
- Acquired Progressive Kinking of Hair
- Differential diagnosis of hair loss in children. Differentialdiagnose des Haarausfalls bei Kindern
- Congenital adrenal hyperplasia
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Hormonal Parameters in Androgenetic Hair Loss in the Male
- Sleep disturbances in women with polycystic ovary syndrome
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Systemic causes of hair loss
- From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Skin diseases in consequence of endocrine alterations
- Approach to androgen excess in women: Clinical and biochemical insights
- Menopausal Acne – Challenges And Solutions
- Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
- Antiandrogen therapy for androgenetic alopecia
- Vitamin B<sub>3</sub> (niacin), B<sub>6</sub>, C, and iron intake are associated with the free androgen index, especially in normoandrogenic polycystic ovary syndrome
- Serum 3α-androstanediol-glucuronide is decreased in nonhirsute women with acne vulgaris
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- Silencing the androgen receptor: New skills for antiandrogen oligonucleotide skin and hair therapy
- Association between male pattern baldness and prostate disease: A meta-analysis